Skip to Main Content

Paper Details

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration.
Sci Rep
51
2021
Author NameAffiliation
Jennifer K FredianiEmory University
Jennifer K FredianiThe Atlanta Center for Microsystems-Engineered Point-of-Care Technologies
Joshua M LevyThe Atlanta Center for Microsystems-Engineered Point-of-Care Technologies
Joshua M LevyEmory University School of Medicine
Miriam B VosThe Atlanta Center for Microsystems-Engineered Point-of-Care Technologies
Miriam B VosEmory University School of Medicine
Miriam B Vos
Mark D GonzalezThe Atlanta Center for Microsystems-Engineered Point-of-Care Technologies
Mark D Gonzalez
Mark D GonzalezEmory University School of Medicine
Annette M EsperThe Atlanta Center for Microsystems-Engineered Point-of-Care Technologies
Annette M EsperEmory University School of Medicine
Greg S MartinThe Atlanta Center for Microsystems-Engineered Point-of-Care Technologies
Greg S MartinEmory University School of Medicine
  • 1 - 14

Datasets

Release 1.2